Teladoc Health, Inc.
TDOC
$5.35
-$0.17-3.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.06% | -48.78% | 96.10% | -13.58% | -67.56% |
| Total Depreciation and Amortization | 7.02% | -10.86% | -25.70% | -30.66% | -27.05% |
| Total Amortization of Deferred Charges | 10.16% | 17.92% | 43.99% | 35.68% | 48.50% |
| Total Other Non-Cash Items | -70.02% | -12.33% | -98.12% | 40.35% | -32.51% |
| Change in Net Operating Assets | -61.83% | 66.26% | 240.29% | 22.00% | -1.12% |
| Cash from Operations | 2.14% | -9.90% | 3.10% | 78.46% | -33.96% |
| Capital Expenditure | 57.29% | -42.77% | 33.68% | -137.25% | -336.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.82% | -0.97% | -123.46% | -62.77% | 33.02% |
| Cash from Investing | -15.77% | -56.41% | -115.14% | -247.12% | 18.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -41.39% | -45.98% | -81.82% | -53.31% | 69.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -99.43% | -1,486.49% | -- | -- | 106.10% |
| Cash from Financing | -46.36% | -614.61% | -14,552.90% | -56.08% | 215.94% |
| Foreign Exchange rate Adjustments | 107.99% | -118.43% | 1,636.30% | 276.31% | -386.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.69% | -42.78% | -897.09% | -307.91% | -41.53% |